Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 249 Breast Neoplasms 136 Neoplasms 108 Prostatic Neoplasms 35 Fatigue 35 Obesity 25 Lung Neoplasms 24 Colorectal Neoplasms 24 Polycystic Ovary Syndrome 17 Colonic Neoplasms 16 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Pancreatic Neoplasms 11 Lymphoma 11 Lymphedema 11 Hematologic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Rectal Neoplasms 10 Multiple Myeloma 10 Head and Neck Neoplasms 10 Leukemia 9 Insulin Resistance 8 Cardiotoxicity 8 Brain Neoplasms 8 Stomach Neoplasms 7 Peripheral Nervous System Diseases 7 Overweight 6 Esophageal Neoplasms 6 Cognitive Dysfunction 6

Interventions

Adalimumab 19 Etanercept 16 Methotrexate 11 Infliximab 8 tocilizumab 7 Rituximab 7 golimumab 6 Abatacept 6 tofacitinib 5 Tumor Necrosis Factor Inhibitors 5 olokizumab 4 Certolizumab Pegol 4 Antirheumatic Agents 3 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 cabozantinib 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 TACI receptor-IgG Fc fragment fusion protein 1 Syringes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × Exercise × Clear all

NCT05215509 2024-02-02

RABEX

Rigshospitalet, Denmark

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡